Back to Search Start Over

Novel third-generation tyrosine kinase inhibitor for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a case study

Authors :
Xu Tan
Qin Wen
Guo Chen
Kai Wan
Xue Liu
Ying-Ying Ma
Mai-Hong Wang
Xi Zhang
Cheng Zhang
Source :
Anti-Cancer Drugs. 34:599-604
Publication Year :
2022
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2022.

Details

ISSN :
09594973
Volume :
34
Database :
OpenAIRE
Journal :
Anti-Cancer Drugs
Accession number :
edsair.doi...........7c1b1926fde0fe3af03c9c35ab935469